Literature DB >> 9314120

Analysis of the cell tropism of HCV by using in vitro HCV-infected human lymphocytes and hepatocytes.

M Ikeda1, N Kato, T Mizutani, K Sugiyama, K Tanaka, K Shimotohno.   

Abstract

BACKGROUND/
METHODS: We recently established two hepatitis C virus (HCV) replication systems, using MT-2, a human T-cell leukemia virus type I-infected human T-cell line, and PH5CH, a non-neoplastic human hepatocyte line immortalized with simian virus 40 large T antigen. These HCV replication systems were used to assess the infective potencies of seven sera containing more than 10(6) HCV genomes per ml obtained from HCV-positive blood donors.
RESULTS: The results showed that these sera had different infectivities for MT-2 and PH5CH cells. One of the seven sera, 1B-1, was more infective for MT-2 cells than PH5CH cells, whereas all the sera except serum 1B-1 were more infective for PH5CH cells than for MT-2 cells. Intracellular HCV RNA could be detected at least 30 days after inoculation with three of the sera. These findings suggested that the infective potency of each serum depends on the type of target cells. To further investigate HCV replication in these cells, we examined the hypervariable region 1 (HVR1) populations of HCV recovered from both MT-2 and PH5CH cells at 8 days postinoculation. The results revealed that the shift to limited HVR1 populations from the quasi-species of HVR1 populations in both cells usually occurred within 8 days after virus inoculation. Furthermore, in two of four sera, the predominant HVR1 populations in MT-2 and PH5CH cells appeared to be different.
CONCLUSION: These results suggest that HCV exhibits cell tropism.

Entities:  

Mesh:

Year:  1997        PMID: 9314120     DOI: 10.1016/s0168-8278(97)80347-9

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  8 in total

1.  Hepatitis C virus infection of human hepatoma cell line 7721 in vitro.

Authors:  Z Q Song; F Hao; F Min; Q Y Ma; G D Liu
Journal:  World J Gastroenterol       Date:  2001-10       Impact factor: 5.742

2.  HepG2 cells support viral replication and gene expression of hepatitis C virus genotype 4 in vitro.

Authors:  Mostafa K el-Awady; Ashraf A Tabll; Yasmine S el-Abd; Mahmoud M Bahgat; Hussein A Shoeb; Samar S Youssef; Noha G Bader el-Din; el-Rashdy M Redwan; Maha el-Demellawy; Moataza H Omran; Wael T el-Garf; Said A Goueli
Journal:  World J Gastroenterol       Date:  2006-08-14       Impact factor: 5.742

3.  Nonrandom distribution of hepatitis C virus quasispecies in plasma and peripheral blood mononuclear cell subsets.

Authors:  A M Roque Afonso; J Jiang; F Penin; C Tareau; D Samuel; M A Petit; H Bismuth; E Dussaix; C Féray
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

4.  An antioxidant resveratrol significantly enhanced replication of hepatitis C virus.

Authors:  Mitsuyasu Nakamura; Hidetsugu Saito; Masanori Ikeda; Ryota Hokari; Nobuyuki Kato; Toshifumi Hibi; Soichiro Miura
Journal:  World J Gastroenterol       Date:  2010-01-14       Impact factor: 5.742

5.  Immortalized Human Hepatic Cell Lines for In Vitro Testing and Research Purposes.

Authors:  Eva Ramboer; Tamara Vanhaecke; Vera Rogiers; Mathieu Vinken
Journal:  Methods Mol Biol       Date:  2015

Review 6.  Human cell types important for hepatitis C virus replication in vivo and in vitro: old assertions and current evidence.

Authors:  Dennis Revie; Syed Zaki Salahuddin
Journal:  Virol J       Date:  2011-07-11       Impact factor: 4.099

7.  Transgenic mouse expressing a full-length hepatitis C virus cDNA.

Authors:  J Matsuda; M Suzuki; C Nozaki; N Shinya; K Tashiro; K Mizuno; Y Uchinuno; K Yamamura
Journal:  Jpn J Cancer Res       Date:  1998-02

8.  Lactoferrin inhibits hepatitis C virus viremia in patients with chronic hepatitis C: a pilot study.

Authors:  K Tanaka; M Ikeda; A Nozaki; N Kato; H Tsuda; S Saito; H Sekihara
Journal:  Jpn J Cancer Res       Date:  1999-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.